Editorial
The current and future landscape of radiotherapy for lung cancer
Translational Lung Cancer Research
2019;
8
(Suppl 2)
:S122-S123
.
(12 September 2019)
Review Article
Pathologic response after modern radiotherapy for non-small cell lung cancer
Translational Lung Cancer Research
2019;
8
(Suppl 2)
:S124-S134
.
(12 September 2019)
Safety of stereotactic ablative body radiation for ultracentral stage I non-small cell lung cancer
Translational Lung Cancer Research
2019;
8
(Suppl 2)
:S135-S138
.
(12 September 2019)
PACIFIC: shifting tides in the treatment of locally advanced non-small cell lung cancer
Translational Lung Cancer Research
2019;
8
(Suppl 2)
:S139-S146
.
(12 September 2019)
Recent developments in limited stage small cell lung cancer
Translational Lung Cancer Research
2019;
8
(Suppl 2)
:S147-S152
.
(12 September 2019)
What is the role of radiotherapy for extensive-stage small cell lung cancer in the immunotherapy era?
Translational Lung Cancer Research
2019;
8
(Suppl 2)
:S153-S162
.
(12 September 2019)
What is the optimal radiotherapy utilization rate for lung cancer?—a systematic review
Translational Lung Cancer Research
2019;
8
(Suppl 2)
:S163-S171
.
(12 September 2019)
Strengths and limitations of large databases in lung cancer radiation oncology research
Translational Lung Cancer Research
2019;
8
(Suppl 2)
:S172-S183
.
(12 September 2019)
Changing equipoise in the landscape of radiation for oligometastatic lung cancer
Translational Lung Cancer Research
2019;
8
(Suppl 2)
:S184-S191
.
(12 September 2019)
Current landscape of palliative radiotherapy for non-small-cell lung cancer
Translational Lung Cancer Research
2019;
8
(Suppl 2)
:S192-S201
.
(12 September 2019)
Proton therapy for non-small cell lung cancer: the road ahead
Translational Lung Cancer Research
2019;
8
(Suppl 2)
:S202-S212
.
(12 September 2019)
Management of local recurrences and regional failure in early stage non-small cell lung cancer after stereotactic body radiation therapy
Translational Lung Cancer Research
2019;
8
(Suppl 2)
:S213-S221
.
(12 September 2019)
Disclosure:
The supplement “Recent Developments in Radiotherapy for Lung Cancer” was commissioned by the editorial office, Translational Lung Cancer Research without any sponsorship or funding. Alexander V. Louie, Houda Bahig and Drew Moghanaki served as the unpaid Guest Editors for the supplement.
